Compugen (CGEN) Tops Q4 EPS by 2c

Note: EPS may not be comparable

Compugen (NASDAQ: CGEN) reported Q4 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Deutsche Bank Starts DexCom (DXCM) at Buy
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold